{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-342427","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2021-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.829486+00:00","generated_at":"2026-06-28T05:04:10.013152+00:00","sec_items":["8.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bio-Rad loans €400M to Sartorius-Herbst at 1.5% plus appreciation rights","bullets":["Loan of €400 million to Sartorius-Herbst Beteiligungen II GmbH at 1.5% per annum plus value appreciation rights.","Maturity on January 31, 2029, subject to early termination provisions.","Proceeds used to partially finance acquisition of interests under the Sartorius Trust from another beneficiary.","Loan collateralized by pledge of trust interests under the Sartorius Trust."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-342427","json":"https://secwatch.observer/filing/0001193125-21-342427.json","markdown":"https://secwatch.observer/filing/0001193125-21-342427.md","text":"https://secwatch.observer/filing/0001193125-21-342427.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000119312521342427/0001193125-21-342427-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000119312521342427/d271505d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:04:10.013152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}